X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23286) 23286
Newsletter (428) 428
Book Chapter (123) 123
Newspaper Article (107) 107
Magazine Article (86) 86
Dissertation (47) 47
Conference Proceeding (19) 19
Web Resource (10) 10
Publication (8) 8
Book / eBook (5) 5
Government Document (4) 4
Book Review (3) 3
Paper (2) 2
Streaming Video (2) 2
Reference (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15882) 15882
ribavirin (12639) 12639
antiviral agents - therapeutic use (8707) 8707
male (8662) 8662
female (8341) 8341
hepatitis c, chronic - drug therapy (7577) 7577
ribavirin - therapeutic use (7375) 7375
hepatitis c (7356) 7356
middle aged (7083) 7083
adult (6421) 6421
gastroenterology & hepatology (6165) 6165
interferon (5685) 5685
drug therapy, combination (5656) 5656
hepatitis c virus (5413) 5413
interferon-alpha - therapeutic use (5114) 5114
treatment outcome (4803) 4803
hepacivirus - genetics (4255) 4255
genotype (3837) 3837
recombinant proteins (3492) 3492
therapy (3462) 3462
plus ribavirin (3299) 3299
infectious diseases (3204) 3204
infection (3201) 3201
antiviral agents - administration & dosage (3176) 3176
aged (3159) 3159
ribavirin - administration & dosage (3157) 3157
hepatitis c - drug therapy (3108) 3108
virology (2919) 2919
hepatitis (2905) 2905
polyethylene glycols - therapeutic use (2863) 2863
health aspects (2801) 2801
antiviral agents - adverse effects (2703) 2703
virus-infection (2600) 2600
hepatitis c, chronic - virology (2525) 2525
hepacivirus - drug effects (2492) 2492
pharmacology & pharmacy (2453) 2453
antiviral agents (2305) 2305
interferon-alpha - administration & dosage (2229) 2229
care and treatment (2121) 2121
biological response modifiers (2120) 2120
ribavirin - adverse effects (2087) 2087
hcv (2078) 2078
viral load (2076) 2076
animals (1912) 1912
drug therapy (1847) 1847
interferon-alpha - adverse effects (1821) 1821
antiviral agents - pharmacology (1820) 1820
virus diseases (1812) 1812
hepatitis c, chronic - complications (1808) 1808
pegylated interferon (1800) 1800
sustained virological response (1780) 1780
liver (1742) 1742
chronic hepatitis c (1707) 1707
viruses (1699) 1699
immunology (1682) 1682
analysis (1656) 1656
infections (1648) 1648
cirrhosis (1611) 1611
rna, viral - blood (1609) 1609
chronic hepatitis-c (1555) 1555
combination therapy (1523) 1523
risk factors (1490) 1490
virus (1488) 1488
ribavirin - pharmacology (1480) 1480
retrospective studies (1461) 1461
combination (1452) 1452
genetic aspects (1439) 1439
recombinant proteins - therapeutic use (1420) 1420
research (1420) 1420
microbiology (1409) 1409
medicine, general & internal (1395) 1395
peginterferon (1332) 1332
sofosbuvir (1308) 1308
time factors (1277) 1277
interferons - therapeutic use (1268) 1268
polyethylene glycols - administration & dosage (1264) 1264
peginterferon alpha-2a (1211) 1211
rna (1210) 1210
adolescent (1179) 1179
interferon-alpha (1172) 1172
genotypes (1167) 1167
initial treatment (1158) 1158
antiviral therapy (1152) 1152
hepacivirus - isolation & purification (1151) 1151
patients (1147) 1147
young adult (1126) 1126
hiv (1123) 1123
efficacy (1106) 1106
hepatitis c - virology (1094) 1094
transplantation (1091) 1091
hepatitis c - complications (1089) 1089
recurrence (1088) 1088
hiv infections - complications (1077) 1077
gastroenterology and hepatology (1076) 1076
fibrosis (1072) 1072
prospective studies (1056) 1056
telaprevir (1048) 1048
hepatocellular-carcinoma (1002) 1002
liver cirrhosis (999) 999
prevalence (971) 971
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (22221) 22221
French (405) 405
Spanish (391) 391
German (320) 320
Japanese (298) 298
Korean (200) 200
Portuguese (198) 198
Russian (198) 198
Chinese (168) 168
Polish (110) 110
Hungarian (66) 66
Czech (50) 50
Italian (50) 50
Turkish (35) 35
Croatian (21) 21
Serbian (17) 17
Dutch (13) 13
Danish (8) 8
Hebrew (6) 6
Finnish (5) 5
Slovak (5) 5
Swedish (5) 5
Arabic (3) 3
Bosnian (3) 3
Norwegian (3) 3
Persian (3) 3
Romanian (3) 3
Lithuanian (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Catalan (1) 1
Icelandic (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2014, Volume 370, Issue 17, pp. 1604 - 1614
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2014, Volume 147, Issue 2, pp. 359 - 365.e1
Background & Aims The interferon-free regimen of ABT-450 (a protease inhibitor), ritonavir, ombitasvir (an NS5A inhibitor), dasabuvir (a non-nucleoside... 
Gastroenterology and Hepatology | IFN | PEARL-II | Ribavirin-Free | Interferon-Free Therapy | PLUS RIBAVIRIN | ABT-450/R-OMBITASVIR | VIRUS-INFECTION | TELAPREVIR | SOFOSBUVIR | CHRONIC HEPATITIS-C | COMBINATION | TRIAL | CIRRHOSIS | BOCEPREVIR | GASTROENTEROLOGY & HEPATOLOGY | Anilides - therapeutic use | Puerto Rico | Hepatitis C - drug therapy | United States | Anilides - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Male | RNA, Viral - blood | Viral Load | Ritonavir - adverse effects | Time Factors | Ritonavir - therapeutic use | Adult | Female | Drug Therapy, Combination | Hepacivirus - drug effects | Antiviral Agents - therapeutic use | Europe | Ribavirin - therapeutic use | Uracil - therapeutic use | Genotype | Treatment Outcome | Macrocyclic Compounds - adverse effects | Biomarkers - blood | Macrocyclic Compounds - therapeutic use | Hepatitis C - diagnosis | Uracil - adverse effects | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Sulfonamides - adverse effects | Carbamates - adverse effects | Hepacivirus - growth & development | Aged | Carbamates - therapeutic use | Uracil - analogs & derivatives | Medical colleges | Care and treatment | Proteases | Ritonavir | Biological products industry | Genetic aspects | Biological response modifiers | Hepatitis C virus | Hepatitis C | Health aspects | Ribavirin
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2015, Volume 148, Issue 1, pp. 108 - 117
Background & Aims Interferon alfa–based regimens used to treat recurrent hepatitis C virus (HCV) infection after liver transplantation are poorly tolerated,... 
Gastroenterology and Hepatology | Antiviral Agent | Clinical Trial | DAA | NS5B Polymerase Inhibitor | PLUS RIBAVIRIN | MULTICENTER | ANTIVIRAL THERAPY | EFFICACY | HCV GENOTYPE 1 | GRAFT | COMBINATION | INTERFERON | DYSFUNCTION | GASTROENTEROLOGY & HEPATOLOGY | DRUG-DRUG INTERACTIONS | Recurrence | Prospective Studies | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Liver Transplantation - adverse effects | United States | Humans | Drug Resistance, Viral | Hepacivirus - genetics | Hepacivirus - pathogenicity | Male | RNA, Viral - blood | Viral Load | Time Factors | Ribavirin - pharmacokinetics | Female | Hepatitis C - complications | Uridine Monophosphate - adverse effects | Drug Therapy, Combination | Uridine Monophosphate - therapeutic use | Hepacivirus - drug effects | Liver Neoplasms - virology | Liver Cirrhosis - diagnosis | Antiviral Agents - therapeutic use | Carcinoma, Hepatocellular - diagnosis | Ribavirin - therapeutic use | Carcinoma, Hepatocellular - surgery | Genotype | Liver Neoplasms - surgery | Treatment Outcome | Carcinoma, Hepatocellular - virology | Biomarkers - blood | Spain | New Zealand | Hepatitis C - diagnosis | Pilot Projects | Liver Cirrhosis - virology | Liver Neoplasms - diagnosis | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Liver Cirrhosis - surgery | Uridine Monophosphate - pharmacokinetics | Sofosbuvir | Virus diseases | Relapse | Liver | Transplantation | Biological response modifiers | Drug therapy | Hepatitis C virus | Health aspects | Immunosuppressive agents | Ribavirin | Diseases
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 20, pp. 1867 - 1877
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 20, pp. 1878 - 1887
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9742, pp. 705 - 716
Journal Article
Gastroenterology, ISSN 0016-5085, 2008, Volume 135, Issue 2, pp. 451 - 458
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 360, Issue 18, pp. 1839 - 1850
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 3, pp. 216 - 224
Journal Article